SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,266,000 | -3.8% | 68,470 | +1.9% | 0.09% | 0.0% |
| Q1 2019 | $2,355,000 | -6.5% | 67,220 | -11.3% | 0.09% | -32.3% |
| Q4 2018 | $2,519,000 | -34.1% | 75,820 | -0.2% | 0.13% | -3.1% |
| Q3 2018 | $3,825,000 | -15.9% | 75,970 | 0.0% | 0.13% | -20.1% |
| Q2 2018 | $4,547,000 | +42.3% | 75,970 | +8.9% | 0.16% | +40.2% |
| Q1 2018 | $3,195,000 | +17.8% | 69,765 | +0.5% | 0.12% | +24.5% |
| Q4 2017 | $2,712,000 | -2.4% | 69,450 | 0.0% | 0.09% | -12.1% |
| Q3 2017 | $2,778,000 | -29.7% | 69,450 | -24.2% | 0.11% | -32.3% |
| Q2 2017 | $3,949,000 | +41.8% | 91,625 | +3.0% | 0.16% | +49.1% |
| Q1 2017 | $2,784,000 | +31.3% | 88,950 | +5.9% | 0.11% | +23.3% |
| Q4 2016 | $2,121,000 | – | 84,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |